The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Effects of Celecoxib and Naproxen on Renal Function in the Elderly
Abstract
OBJECTIVE: To compare the effects of celecoxib, a cyclooxygenase 2-specific inhibitor, with the nonspecific cyclooxygenase 1 and 2 inhibitor naproxen on renal function in 29 healthy elderly subjects in a single-blind, randomized, crossover study. METHODS: Subjects received either celecoxib, 200 mg twice daily, for 5 days followed by celecoxib, 400 mg twice daily, for the next 5 days, or they received naproxen, 500 mg twice daily, for 10 days. After a 7-day washout, subjects were crossed over to receive the other regimen. RESULTS: After the first dose, the trend was for a greater decrease in glomerular filtration rate with naproxen (-5.31 mL/min per 1.73 m2) compared with celecoxib (-0.86 mL/min per 1.73 m2). The treatment difference became statistically significant on day 6 (-7.53 vs -1.11 mL/min per 1.73 m2 for naproxen and celecoxib, respectively; P=.004). Urinary prostaglandin E2 and 6-keto-prostaglandin F1alpha excretion was significantly reduced from baseline across the treatment interval with both celecoxib and naproxen (P< or =.04). There were no significant differences in prostaglandin excretion between these 2 agents (P> or =.07). Small, transient decreases (P<.05) in urinary sodium excretion were observed after the initiation of both celecoxib and naproxen treatment. Sodium excretion values returned to baseline by the end of the study. CONCLUSIONS: The results indicate that cyclooxygenase 2-specific inhibition in healthy elderly subjects may spare renal hemodynamic function, although the effects on sodium excretion, as well as urinary prostaglandin E2 and 6-keto-prostaglandin F1alpha excretion, appear to be similar to those of nonspecific cyclooxygenase inhibitors such as naproxen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., Dubois, R. N., & Breyer, M. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117620 · Cited by 860
Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues
O'Neill, G. P., & Ford-Hutchinson, A. W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80263-t · Cited by 707
Whelton, A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00113-8 · Cited by 704
Self-citationCOX-1 and COX-2 tissue expression: implications and predictions.
Crofford, L. J. (1997) · PubMed · Cited by 675
EPIDEMIOLOGY OF HIP AND KNEE OSTEOARTRRITIS1
FELSON, D. T. (1988) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036019 · Cited by 630
Heffelfinger, J. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1399 · Cited by 610
Catella-Lawson, F., McAdam, B., Morrison, B. W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K. C., Quan, H., Gertz, B. J., & Fitzgerald, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 597
Felson, D. T., Anderson, J. J., Lange, M. L. M., Wells, G., & LaValley, M. P. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9 · Cited by 474
Kargman, S., Charleson, S., Cartwright, M., Frank, J., Riendeau, D., Mancini, J., Evans, J., & O'Neill, G. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8690211 · Cited by 462
Epstein, M. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v781106 · Cited by 442
Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase
Gierse, J. K., Hauser, S. D., Creely, D. P., Koboldt, C., Rangwala, S. H., Isakson, P. C., & Seibert, K. (1995) · Biochemical Journal · doi:10.1042/bj3050479 · Cited by 412
Self-citationMechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.
Copeland, R. A., Williams, J. M., Giannaras, J., Nurnberg, S., Covington, M., Pinto, D., Pick, S., & Trzaskos, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11202 · Cited by 408
Lackland, D. T., Bendall, H. E., Osmond, C., Egan, B. M., & Barker, D. J. P. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1472 · Cited by 368
Komhoff, M., Grone, H. J., Klein, T., Seyberth, H. W., & Nusing, R. M. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.272.4.f460 · Cited by 365
The clinical significance of inhibition of renal prostaglandin synthesis
Patrono, C., & Dunn, M. J. (1987) · Kidney International · doi:10.1038/ki.1987.164 · Cited by 296
Nonsteroidal Anti-inflammatory Drugs and the Risk for Chronic Renal Disease
Sandler, D. P., Burr, F. R., & Weinberg, C. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-165 · Cited by 213
Whelton, A., Stout, R. L., Spilman, P. S., & Klassen, D. K. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-568 · Cited by 204
Self-citationKhan, K. N. M., Venturini, C. M., Bunch, R. T., Brassard, J. A., Koki, A. T., Morris, D. L., Trump, B. E., Maziasz, T. J., & Alden, C. L. (1998) · Toxicologic Pathology · doi:10.1177/019262339802600504 · Cited by 201
Identification of Risk for Renal Insufficiency From Nonsteroidal Anti-inflammatory Drugs
Blackshear, J. L. (1983) · Archives of Internal Medicine · doi:10.1001/archinte.143.6.1130 · Cited by 168
Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Celecoxib in Rats
Paulson, S. K., Zhang, J. Y., Breau, A. P., Hribar, J. D., Liu, N. W. K., Jessen, S. M., Lawal, Y. M., Cogburn, J. N., Gresk, C. J., Markos, C. S., et al. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15094-5 · Cited by 151
Changes in Renal Function with Aging
Beck, L. H. (1998) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30113-7 · Cited by 143
Renal Identification of Cyclooxygenase-2 in a Subset of Thick Ascending Limb Cells
Vio, C. P., Céspedes, C., Gallardo, P. A., & Masferrer, J. L. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.687 · Cited by 138
Gastrointestinal effects of nonsteroidal anti-inflammatory therapy
Raskin, J. B. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00112-6 · Cited by 113
Renal Effects of Nonsteroidal Antiinflammatory Drugs
Lamy, P. P. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb04319.x · Cited by 54
Nephrotoxicity of Common Drugs Used in Clinical Practice-Reply
Bennett, W. M. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010239028 · Cited by 47
Effects of aging and drugs on normal renal function.
Lash, J. P., & Gardner, C. (1997) · PubMed · Cited by 14
Infusion clearance of subcutaneous iothalamate versus standard renal clearance
Sharma, A., Mills, M., Grey, V. L., & Drummond, K. N. (1997) · Pediatric Nephrology · doi:10.1007/s004670050372 · Cited by 13
EFFECTS OF NAPROXEN ON RENAL FUNCTION IN OLDER PATIENTS WITH MILD TO MODERATE RENAL DYSFUNCTION
Simon, L. S., Basch, C. M., Young, D. Y., & ROBINSON, D. R. (1992) · Lara D. Veeken · doi:10.1093/rheumatology/31.3.163 · Cited by 11
Cited by
Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
Warner, T. D., & Mitchell, J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0645rev · Cited by 614
Schoolwerth, A. C., Sica, D. A., Ballermann, B. J., & Wilcox, C. S. (2001) · Circulation · doi:10.1161/hc4101.096153 · Cited by 363
Whelton, A., Fort, J. G., Puma, J. A., Normandin, D., Bello, A. E., & Verburg, K. M. (2001) · American Journal of Therapeutics · doi:10.1097/00045391-200103000-00003 · Cited by 334
Self-citationZhang, J., Ding, E. L., & Song, Y. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60015 · Cited by 332
Metadata
- Authors
- Whelton, A., Schulman, G., Wallemark, C., Drower, E. J., Isakson, P. C., Verburg, K. M., & Geis, G. S.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2000-05-22
- Volume
- 160
- Issue
- 10
- Pages
- 1465
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2146625461
- Cited by
- 280
- References
- 30
- FWCI
- 23.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.